Carbonic anhydrase inhibitors show potential in reducing tau protein buildup, offering new therapeutic avenues for neurodegenerative diseases like tauopathies.

Researchers have discovered that methazolamide, a glaucoma drug, can clear tau protein build-up in the brain, a key factor in dementias like Alzheimer's. This study, using zebrafish and mice models, s ...

A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of ...

Glaucoma drug methazolamide shows potential in fighting neurodegenerative diseases, offering new hope for treating conditions ...

Researchers in the UK Dementia Research Institute at the University of Cambridge in the UK focussed on a class of drugs known ...

They are mainly comprised of five types, including thiazides, loop diuretics, potassium-sparring diuretics, carbonic anhydrase inhibitors, and osmotic diuretics. Diuretics can be prescribed to treat ...

A drug used to treat glaucoma may protect against tau protein buildup in the brain, a key marker of dementias such as ...

If this is indeed their biological function, it would represent the first documented Cu-based carbonic anhydrase. The ...

A new study shows that a common glaucoma drug cleared tau build-up and reduced signs of neurodegenerative disease in zebrafish and mice.

1 Prostate-specific membrane antigen. 2 Carbonic anhydrase IX. 3 TLX102 labelled with astatine-211. All other listed alpha therapies labelled with actinium-225. 4 Large amino acid transporter 1. 5 ...